Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia.
Additionally, patients with the LAAO device had a lower risk for gastrointestinal bleeding, hospitalization, rehospitalization, and shorter length of stay compared with those who didn't undergo LAAO intervention. The question the investigators sought to answer here was whether cannabidiol, which is a selective cannabinoid receptor agonist with limited side effects in the central nervous system, would also modulate effects related to sensation. They looked at an oral formulation of a purified cannabidiol approved by the US Food and Drug Administration .
I therefore think buspirone should be considered. It has a very low downside in patients with moderate to severe fullness and symptoms of severe bloating.There were multiple studies on the use of AI and other computer-assisted developments for improving colonoscopy. This has been talked about quite often as revolutionizing endoscopy in so many ways, yet several studies broke with this idea by presenting the idea that maybe it isn't quite needed in all regards.
It's something that patients could do at home, although obviously it diminishes some of the healthcare-provided interventions. But again, this is very promising and simple to use, with minimal costs. In the short term, I think it's very easy to administer.Finally, there was an interesting study on a potassium-competitive acid blocker, vonoprazan.